Dr. Kalbasi is a physician-scientist at Stanford University. In the clinic, he specializes in the treatment of patients with solid tumors, especially sarcoma and melanoma. Dr. Kalbasi's NIH-funded laboratory studies the cancer-immune interface in emerging therapeutic contexts, including T cell therapy, cytokine therapy and innate immune agonism. Dr. Kalbasi is also an experienced leader of clinical trials related to immunotherapy, T cell therapy and radiation therapy.